Mavacamten in Symptomatic Patients Resistant to Previous Advanced Therapy for Obstructive Hypertrophic Cardiomyopathy

Background The clinical benefits of mavacamten in patients with obstructive hypertrophic cardiomyopathy previously treated with advanced therapies are not established. Methods Clinical and echocardiographic outcomes of patients treated with mavacamten for left ventricular outflow obstruction for at...

Full description

Bibliographic Details

Main Authors:	Daniele Massera, Elizabeth Adlestein, Sumar Frejat, Woon Y. Wu, Maria C. Reuter, Yuhe Xia, Isabel C. Alvarez, Mark V. Sherrid
Format:	Artigo
Language:	Inglês
Published:	Wiley 2025-08-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	cardiac myosin inhibitor hypertrophic cardiomyopathy left ventricular outflow obstruction
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.125.041565
Tags:	Add Tag No Tags, Be the first to tag this record!